
-
With eye on US threat, Venezuela holds Caribbean military exercises
-
Only 40% of countries have booked lodging for Amazon climate meet
-
Louboutin taps Jaden Smith to lead well-heeled shoemaker's men's line
-
Pakistan beat UAE to set up India rematch in Asia Cup
-
US Fed makes first rate cut of 2025 over employment risks
-
US sprint star Kerley joins drug-fueled Enhanced Games
-
Decaying body found in US rapper's Tesla identified as teen girl
-
Flick backs 'unbelievable' Rashford to shine in Yamal absence
-
Mourinho poised for Benfica return after Lage sacking
-
US Fed makes first rate cut of 2025 on employment risks
-
Fired US health agency chief says was under RFK Jr 'pressure' to ignore science
-
Brazil's Bolsonaro adds skin cancer to medical woes
-
Colombia vows to fight drug trade 'with or without' the US
-
Germany's Merz criticises festival for axing Israeli conductor
-
Thousands protest in London over Trump UK visit
-
Fired US health agency chief testifies on pressure to 'replace evidence with ideology'
-
Palestinians flee Gaza City in face of deadly Israeli offensive
-
England take Salt path to victory over Ireland in first T20
-
French strikes hit Bayeux Tapestry transfer ahead of UK loan
-
New York officials sink Times Square casino bid
-
Canada central bank cuts key lending rate citing Trump tariffs
-
Pakistan Asia Cup match belatedly goes ahead amid India handshake row
-
Nader pulls off shock in 1,500 metres, Moon rises to pole vault challenge at worlds
-
Ex-US climate envoy: Trump threatening 'consensus science' worldwide
-
EU proposes action on Israel trade and ministers over Gaza
-
US Treasury official expected to be named IMF's second-in-command: source
-
Man City 'apparently' not Champions League contenders: Guardiola
-
EU says India's Russia links jeopardise closer ties
-
Ukraine reach BJK Cup semi-finals for first time
-
Benjamin sets up 'historic' hurdles showdown with Warholm and Dos Santos
-
Milan-Cortina bobsleigh track 'surpasses expectations', say Winter Olympics organisers
-
Stocks, dollar calm ahead of expected US rate cut
-
Nvidia CEO disappointed over China chip ban report
-
Portugal's Isaac Nader wins world men's 1,500m gold
-
France launches appeal to acquire Proust's 'madeleine' writings
-
East Timor to scrap MP pensions and SUVs after protests
-
Van Niekerk enjoys second wind in Tokyo after injury nightmare
-
American Moon wins third straight world pole vault gold
-
King gives Trump royal welcome on UK state visit
-
Man Utd post sixth straight annual loss despite record revenues
-
Australian teen Gout Gout revels in world championships debut
-
AI may boost global trade value by nearly 40%: WTO
-
New Zealand star Miller out of Women's Rugby World Cup semi-final
-
Lyles and Gout Gout advance to world 200m semi-finals
-
S.Africa commission begins probe into alleged links between politics and crime
-
PSG women in audacious bid to sign Barca's Putellas
-
Jefferson-Wooden eases into world 200m semis and sets sights on being next Fraser-Pryce
-
Germany's Merz vows 'autumn of reforms' in turbulent times
-
EU says India's Russian oil purchases, military drills hinder closer ties
-
Gold worth 600,000 euros stolen in Paris museum heist

Chinese medical portal censored after doubting herbal 'Covid remedy'
A popular Chinese medical information site has been censored by authorities for "violation of relevant laws and regulations", months after its criticism of a government-backed herbal Covid-19 treatment sent shares in a pharmaceutical giant tumbling.
DXY, which counts tech giant Tencent among its investors and runs a host of health-related services, previously questioned the value of Lianhua Qingwen, a herbal remedy marketed for fever and sore throats, as a Covid-19 treatment.
China approved the concoction -- made up of ingredients like honeysuckle and apricot seeds -- as a Covid-19 treatment in 2020, and it was distributed to Shanghai residents during the city's outbreak this year.
DXY's article was part of a wave of reports that caused shares in Lianhua Qingwen's producer -- one of China's largest traditional medicine companies -- to plunge.
The website has now been banned from posting on at least five of its Weibo social media accounts, with a notice at the top of its official page saying that due to "violation of relevant laws and regulations, this user is currently prohibited from posting".
DXY's official WeChat accounts, which typically publish multiple articles a day on medical topics, have not been updated since Monday.
The Weibo notice did not specify which regulations had been violated by DXY, which did not immediately respond to AFP's request for comment.
The Chinese government has increasingly promoted traditional medicine at home and abroad in recent years, often with nationalistic undertones.
DXY's coverage prompted criticism that it was targeting traditional Chinese medicine (TCM) in order to promote Western pharmaceuticals.
The United States and other countries have warned there is no evidence Lianhua Qingwen works to prevent or cure Covid-19, even as it has increasingly been promoted by government authorities in China and Hong Kong.
The US Food and Drug Administration has said it has not approved Lianhua Qingwen and that coronavirus-related claims about it were "not supported by competent and reliable scientific evidence".
Beijing issued its first white paper on TCM in 2016, laying out plans to build medicine centres and dispatch practitioners to developing countries in Africa and Southeast Asia.
President Xi Jinping has described TCM as a "treasure of Chinese civilisation" and has said that it should be given as much weight as other treatments.
Beijing's National Health Commission has also dispatched TCM practitioners as part of its medical reinforcement teams sent to fight Covid-19 outbreaks across the country.
M.Fischer--AMWN